SCHEMBL22270626

SCHEMBL22270626

C=C(Cc1ccc(CCC)cc1)Nc1ccc(-c2nccnc2-c2ccc(C)cc2F)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 4/20 0.35
▸ LCK P06239 3/20 0.35
▸ FLT1 P17948 3/20 0.35
▸ FLT4 P35916 3/20 0.35
▸ FLT3 P36888 3/20 0.35
▸ ROCK2 O75116 2/20 0.35
▸ MAP4K4 O95819 2/20 0.35
▸ AXL P30530 2/20 0.35
▸ FRK P42685 2/20 0.35
▸ CLK2 P49760 2/20 0.35
▸ BLK P51451 2/20 0.35
▸ CSNK1G2 P78368 2/20 0.35
▸ ROCK1 Q13464 2/20 0.35
▸ AURKB Q96GD4 2/20 0.35
▸ CLK4 Q9HAZ1 2/20 0.35
▸ CSNK1G1 Q9HCP0 2/20 0.35
▸ MAP4K5 Q9Y4K4 2/20 0.35
▸ CSNK1G3 Q9Y6M4 2/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ ITK Q08881 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22270835 0.79 KDR (0.42) KDRMAPTSMN1; SMN2NPC1TP53
SCHEMBL18448521 0.76 RORC (0.49) RORCSMN1; SMN2GAARAB9AWNT3A
SCHEMBL22270870 0.74 TRPV1 (0.42) MAPTSMN1; SMN2GAARAB9ATRPV1
SCHEMBL22271066 0.74 RORC (0.35) RORCMAPT
SCHEMBL22271074 0.74 CA12 (0.37) SMN1; SMN2GAANPC1TP53PKM
SCHEMBL22270863 0.74 GSK3B (0.38) LCKFLT3MAP4K4ROCK1AURKB
SCHEMBL22271057 0.73 TRPV1 (0.43) RORCSMN1; SMN2GAANPC1RAB9A
SCHEMBL22270537 0.71 MAPT (0.36) KDRMAPTSMN1; SMN2GAANPC1
SCHEMBL10980866 0.70 RARB (0.49) HDAC1MAPTSMN1; SMN2KDM1ANPC1
SCHEMBL15451320 0.69 RARB (0.48) HDAC1SMN1; SMN2KDM1ANPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3686187-A1 PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2020-07-29 — — EP disclosed
Send feedback